[annotation] RNA trimethylguanosine cap binding query
Valerie Wood
val at sanger.ac.uk
Wed Jan 16 08:52:01 PST 2008
I recently used the term RNA trimethylguanosine cap binding
to annotate pombe telomerase RNA and represent the fact that this is
trimethylguanosine capped, but on re-reading the definition
I'm not sure if this is correct?
Can I use this for the modification itself?
or is it for gene products which interact with a capped product?
There do not appear to be any other annotations to this term despite
the fact that many RNAs are capped which is another reason which made me
suspect my usage may be wrong.
Should the binding terms should only be used for non-covalent
modifications (although this is only in some of the binding defs?), and
does not represent the use of some terms. For instance GPI anchor
binding is used for a number of proteins which are GPI anchored, in
addition to proteins which bins the GPI moiety during GPI anchor
biosynthesis.
Cheers
Val
Def:
Interacting selectively with the trimethylguanosine (m(3)(2,2,7)-GTP)
moiety located at the 5' end of some RNA molecules. Such trimethylated
cap structures, generally produced by posttranscriptional modification
of a 7-methylguanosine cap, are often found on snRNAs and snoRNAs
transcribed by RNA polymerase II, but have also be found on snRNAs
transcribed by RNA polymerase III. They have also been found on a subset
of the mRNA population in some species, e.g. C. elegans.
--
The Wellcome Trust Sanger Institute is operated by Genome Research
Limited, a charity registered in England with number 1021457 and a
company registered in England with number 2742969, whose registered
office is 215 Euston Road, London, NW1 2BE.
More information about the Annotation
mailing list